The stock market saw a decline on Tuesday as Wall Street shifted away from AI and momentum stocks, while underperformers like Adobe and Intuit rallied. The overall market sentiment remains positive, buoyed by expected earnings growth across the economy as investors consider purchasing stocks outside the recent AI-driven surge.
Investors are particularly encouraged to look for strong, underpriced stocks trading under $10. The Oncology Institute (TOI), a medical services company focused on value-based cancer care, has shown significant growth, averaging a 25% revenue increase over the past four years and projecting a 30% revenue growth in 2026. Currently trading around $5.60 per share, TOI’s average price target indicates a potential upside of approximately 43%.
According to Zacks Investment Research, TOI has achieved a Zacks Rank #2 (Buy) and is expected to decrease its adjusted loss per share from -$0.54 in 2025 to -$0.12 in 2027, suggesting a path toward profitability. The stock has risen over 1,000% in the past two years but remains roughly 45% below its 2021 IPO highs.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
